Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcin...
Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
AimsSpecial AT-rich sequence-binding protein 2 (SATB2) is a novel immunomarker that is expressed in glandular cells of the lower gastrointestinal tract with retained expression in the majority of primary and metastatic colorectal adenocarcinomas (CRCs). Because of its tissue specificity, SATB2 has been shown to be a clinically useful marker to dist...
Alternative Titles
Full title
Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1846394243
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1846394243
Other Identifiers
ISSN
0021-9746
E-ISSN
1472-4146
DOI
10.1136/jclinpath-2015-203588
